Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Choksi AsiaBOM:530427 +1.56%52 Net Margin % is 6.34% as of Mar. 2026, which is 21% above its 10-year median of 5.26. GuruFocus rates BOM:530427 with a GF Score™ of 52/100. The stock has 8 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Choksi Asia ranks better than 75.12% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Choksi Asia's Net Income for the
three
months ended in Mar. 2026 was ₹7.5 Mil. Choksi Asia's Revenue for the
three
months ended in Mar. 2026 was ₹118.6 Mil. Therefore, Choksi Asia's net margin for the quarter that ended in Mar. 2026 was 6.34%.
The historical rank and industry rank for Choksi Asia's Net Margin % or its related term are showing as below:
BOM:530427'
s Net Margin % Range Over the Past 10 Years
Min: -66.15 Med: 5.26 Max: 16.77
Current: 10.75
BOM:530427's Net Margin % is ranked better than 75.12% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs BOM:530427: 10.75
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Choksi Asia Net Margin % Related Terms
Choksi Asia Net Margin % Historical Data
* Premium members only.
The historical data trend for Choksi Asia's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:530427 vs ABT, SYK, MDT: Net Margin % Comparison
For the Medical Devices subindustry, Choksi Asia's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Choksi Asia Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Choksi Asia's Net Margin % distribution charts can be found below:
* The bar in red indicates where Choksi Asia's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Choksi Asia (BOM:530427) has a Net Margin % of 6.34% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Choksi Asia and its competitors. This is 21% above median its historical median of 5.26. According to the industry distribution chart, Choksi Asia ranks #203 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 24.9%.
Is Choksi Asia's Net Margin % too high?
Choksi Asia's current Net Margin % of 6.34% is 21% above median its 10-year median of 5.26. The Medical Devices & Instruments industry median Net Margin % is 2.07. Choksi Asia's value of 6.34% is 206.3% above this industry median. Based on the distribution chart, Choksi Asia ranks #203 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Choksi Asia has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Choksi Asia's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Choksi Asia ranks #203 out of 816 companies for Net Margin %. This places Choksi Asia in the top 25% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.07. Choksi Asia's value of 6.34% is 206.3% above this benchmark. While the company's 10-year median is 5.26 vs. the industry median of 2.07, Choksi Asia has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Choksi Asia's current Net Margin % of 6.34% is 206.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Choksi Asia and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Choksi Asia's current Net Margin % is 6.34%, which is 21% above median its own 10-year median of 5.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Choksi Asia stock overvalued right now?
Choksi Asia (BOM:530427) has a current Net Margin % of 6.34%. The current Net Margin % is 6.34%, which is 21% above median its 10-year median of 5.26 and 206.3% above the Medical Devices & Instruments industry median of 2.07. Choksi Asia's overall GF Score™ is 52/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Choksi Asia (BOM:530427), the current Net Margin % is 6.34% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Choksi Asia Ltd formerly Choksi Imaging Ltd is an India-based company engaged in the manufacturing of photosensitized materials, medical X-rays, and other healthcare products. The company sells and derives revenue from products like X-ray films, ultrasound, computed radiography systems, specialty X-ray films, etc. In addition, the company also offers maintenance services for X-ray processors, equipment, and computer radiography systems. The firm provides various photographic, and ultrasonic sound services in association with Protec, Medtron, and others.
52GF Score
Get the complete analysis for BOM:530427
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530427 has been successfully added to your 
